ArticleOncotarget2015

XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.

Chang-Jiang Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.